Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction

William Y. Ho; Joseph N. Blattman; Michelle L. Dossett; Cassian Yee; Philip D. Greenberg

doi:10.1016/S1535-6108(03)00113-2

Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction

William Y. Ho, Joseph N. Blattman, Michelle L. Dossett, Cassian Yee, Philip D. Greenberg

Research output: Contribution to journal › Review article › peer-review

133 Scopus citations

Abstract

Adoptive T cell immunotherapy is an evolving technology with the potential of providing a means to safely and effectively target tumor cells for destruction.

Original language	English (US)
Pages (from-to)	431-437
Number of pages	7
Journal	Cancer cell
Volume	3
Issue number	5
DOIs	https://doi.org/10.1016/S1535-6108(03)00113-2
State	Published - May 2003
Externally published	Yes

ASJC Scopus subject areas

Oncology
Cancer Research

Access to Document

10.1016/S1535-6108(03)00113-2

Cite this

@article{de1bd23edf444f459e3c6121f8c7a79e,

title = "Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction",

abstract = "Adoptive T cell immunotherapy is an evolving technology with the potential of providing a means to safely and effectively target tumor cells for destruction.",

author = "Ho, {William Y.} and Blattman, {Joseph N.} and Dossett, {Michelle L.} and Cassian Yee and Greenberg, {Philip D.}",

year = "2003",

month = may,

doi = "10.1016/S1535-6108(03)00113-2",

language = "English (US)",

volume = "3",

pages = "431--437",

journal = "Cancer cell",

issn = "1535-6108",

publisher = "Cell Press",

number = "5",

}

TY - JOUR

T1 - Adoptive immunotherapy

T2 - Engineering T cell responses as biologic weapons for tumor mass destruction

AU - Ho, William Y.

AU - Blattman, Joseph N.

AU - Dossett, Michelle L.

AU - Yee, Cassian

AU - Greenberg, Philip D.

PY - 2003/5

Y1 - 2003/5

N2 - Adoptive T cell immunotherapy is an evolving technology with the potential of providing a means to safely and effectively target tumor cells for destruction.

AB - Adoptive T cell immunotherapy is an evolving technology with the potential of providing a means to safely and effectively target tumor cells for destruction.

UR - http://www.scopus.com/inward/record.url?scp=1542404892&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=1542404892&partnerID=8YFLogxK

U2 - 10.1016/S1535-6108(03)00113-2

DO - 10.1016/S1535-6108(03)00113-2

M3 - Review article

C2 - 12781360

AN - SCOPUS:1542404892

SN - 1535-6108

VL - 3

SP - 431

EP - 437

JO - Cancer cell

JF - Cancer cell

IS - 5

ER -

Adoptive immunotherapy: Engineering T cell responses as biologic weapons for tumor mass destruction

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this